Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : APPLIED MEDICAL DEVICES INC (AMDI) -- Ignore unavailable to you. Want to Upgrade?

To: Tony who wrote (11)	9/18/1998 11:19:00 PM
From: Leonard Bertrand	Read Replies (1) \| Respond to of 117

The company's products included the following: 1. Throb-aid which was a ready to use bandage impregnated with a stabilized form of bovine thrombin which was intended to painlessly stop capillary and venous bleeding within seconds. The company had sales of this product in the amount of $117,993 for the nine months ended in January of 1983. 2. Cyclotran I - An electronic bone marrow transplant device which reduced the risk of contamination. The device was approved for marketing by the FDA and had patent protection. The company was anticipating completing a human clinical trial by June of 1983. 3. Prepacell - This was the company's initial product and was originally designed as a bone marrow aspiration device(A device through which bone marrow is obtained for diagnostic purposes). The company believed that the concept was viable but the product did not meet with market acceptance and the company was working to modify the device to make it more versatile. The company also had a marketing agreement with HEM Research inc. to market interferon in Canada but did not meet minimum sales requirements. They blamed HEM for not supplying products. This information was taken from a prospectus for a unit offering in 1983. Len